Nucleotide/Nucleoside analogue therapies (three types)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Nucleotide/Nucleoside analogue therapies (three types), covering 2024-11-29 to 2024-11-29. Get the full timeline:
Most recent: Clinical Trial Update: Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF [NA]